Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Satllte eeins

COMMERCIAL
Sunday, June 28

PE Applied Biosystems 20.00-22.00
An Integrated Approach to Infectious Disease
Genotyping from PE Applied Biosystems
Session Hall V
Contact: Mr Tony Hardware. Tel. [phone]
Wednesday, July 1
Interferon 06.30-08.30
NaturalAlpha Interferons:
A Multi-Functioned Cytokine
Session Hall IV
Contact: Ms Laura Fisher. Tel. [phone]

MSD 09.00-1
Durable Efficacy: Goal ofARTfor
the New Millenium
Session Hall VI
Contact: Mr Andrew Yang. Tel. [phone]
Glaxo Wellcome 12.30-1
Changing Treatment Paradigms Towards
Optimal Patient Care
Satellite Hall 2000
Contact: Dr. Jean-Marc Steens. Tel. [phone]
E Hoffmann-La Roche 15.00-1'
Overcoming Barriers: Strategies
to Maximise Care
Session Hall VI
Contact: Ms I. Marti. Tel. + 41 61 688 7407

1.30

BTG 06.30-08.30
Next Generation Care ofHIV/AIDS Patients:
5.00 Combating the Effects of HIV-Associated
Weight Loss with Anabolic Agents
Session Hall III
Contact: Ms Peggy Evans. Tel. [phone]
Cedars-Sinai Medical Center 06.30-08.30
7.30 New Directions in HIV Therapy
and Quality Survival
Session Hall V
Contact: Mr Bari Laner. Tel. [phone]
(1.5 hours of Category 1 CME Credit will be offered)

Monday, June 29

Agouron 06.30-08.30
Bridging the Gap: Practical Implications
for Optimising Combination Antiretroviral Therapy
Satellite Hall 2000
Contact: Medical Education Collaborative
(MEC)Customer Relations. Tel. [phone]
Bristol-Myers Squibb 17.30-20.00
Impact of Highly Active Therapy:
What Have We Learned Since Vancouver?
Satellite Hall 2000
Contact: Current Medical Directions, Inc.
Ms Anne Farrell. Tel. [phone]
Essex Chemie AG/Schering-Plough 20.00-22.30
Treatment ofAIDS-Related Complications:
- AIDS-Kaposi's Sarcoma
- HCV Co-Infection
Session Hall V
Contact: Ms Eti Harris. Tel. [phone]
Tuesday, June 30
DuPont 06.30-08.30
New Strategies for Sustained HIV Suppression
Satellite Hall 2000
Contact: Mr Tom Bernadzikowski. Tel. [phone]
Boehringer Ingelheim 17.30-20.00
Therapeutic Strategies With Nevirapine -
The Simple Solution for all Patients
Satellite Hall 2000
Contact: Mr Carl Pommer. Tel. [phone]

Triangle 06.30-08.30
Clinical Horizons: New Approaches to
the Pharmacotherapy ofHIVand HBVDisease
Hotel Noga-Hilton
Contact: Mr Julie Klise. Tel. [phone]
Gilead Sciences 17.30-20.00
New Options for HIV Therapy
Satellite Hall 2000
Contact: Ms Margie Poole. Tel. [phone]

Thursday, July 2

Genentech 06.00-08.30
Peripheral Neuropathies in HIVDisease
Session Hall III
Contact: Mr Robert Mackey. Tel. [phone]
Immune Response Corporation 06.30-08.30
State of the Art in HIV-Specific ImmuneBased Therapy
Session Hall IV
Contact: Mr Alexander B. Johns. Tel. [phone]
Abbott International 17.30-20.00
Evolving Strategies in Protease
Inhibitor Therapy
Satellite Hall 2000
Contact: Ms Luiza Towata. Tel + 1 847 938 8383

CONFERENCE WORKBOOK

229